Adalimumab/etanerceptTuberculosis: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2020年 / 1800卷 / 1期

关键词：

D O I：

10.1007/s40278-020-77379-4

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：17 / 17

相关论文

共 50 条

[31] Adalimumab/prednisoloneHerpetic whitlow: case report
Reactions Weekly, 2021, 1852 (1) : 23 - 23
[32] Adalimumab/infliximabInfusion reaction: case report
Reactions Weekly, 2012, 1385 (1) : 6 - 6
[33] Adalimumab/vedolizumabDrug ineffective : case report
Reactions Weekly, 2023, 1969 (1) : 25 - 25
[34] Adalimumab/infliximabMultiple toxicities: case report
Reactions Weekly, 2018, 1731 (1) : 15 - 15
[35] Adalimumab/secukinumab/ustekinumabThrombocytopenia: case report
Reactions Weekly, 2019, 1754 (1) : 21 - 21
[36] Adalimumab/infliximabCutaneous pseudolymphoma: case report
Reactions Weekly, 2014, 1494 (1) : 5 - 5
[37] Adalimumab/infliximabSevere psoriasis: case report
Reactions Weekly, 2017, 1668 (1) : 26 - 26
[38] Adalimumab/infliximabVarious toxicities: case report
Reactions Weekly, 2018, 1691 (1) : 19 - 19
[39] Adalimumab/etanerceptAlopecia areata: case report
Reactions Weekly, 2013, 1477 (1) : 5 - 5
[40] Adalimumab/immunosuppressantsMiliary tuberculosis: case report
Reactions Weekly, 2019, 1736 (1) : 18 - 18

← 1 2 3 4 5 →